Department of Urology, College of Medicine, University of Illinois at Chicago (UIC), Chicago, Illinois, USA.
University of Illinois Cancer Center, Chicago, Illinois, USA.
Environ Health Perspect. 2018 Nov;126(11):117001. doi: 10.1289/EHP3953.
Previous work determined that early life exposure to low-dose Bisphenol A (BPA) increased rat prostate cancer risk with aging. Herein, we report on prostate-specific results from CLARITY-BPA (Consortium Linking Academic and Regulatory Insights on BPA Toxicity), which aims to resolve uncertainties regarding BPA toxicity.
We sought to ) reassess whether a range of BPA exposures drives prostate pathology and/or alters prostatic susceptibility to hormonal carcinogenesis, and ) test whether chronic low-dose BPA targets prostate epithelial stem and progenitor cells.
Sprague-Dawley rats were gavaged daily with vehicle, ethinyl estradiol (EE) or [Formula: see text] BPA/kg-BW during development or chronically, and prostate pathology was assessed at one year. One developmentally exposed cohort was given testosterone plus estradiol ([Formula: see text]) implants at day 90 to promote carcinogenesis with aging. Epithelial stem and progenitor cells were isolated by prostasphere (PS) culture from dorsolateral prostates (DLP) of rats continuously exposed for six months to [Formula: see text] BPA/kg-BW. Gene expression was analyzed by quantitative real time reverse transcription polymerase chain reaction (qRT-PCR).
Exposure to BPA alone at any dose did not drive prostate pathology. However, rats treated with EE, 2.5, 250, or [Formula: see text] BPA/kg-BW plus [Formula: see text] showed greater severity of lateral prostate intraepithelial neoplasia (PIN), and DLP ductal adenocarcinoma multiplicity was markedly elevated in tumor-bearing rats exposed to [Formula: see text]-BW. DLP stem cells, assessed by PS number, doubled with chronic EE and [Formula: see text] exposures. PS size, reflecting progenitor cell proliferation, was greater at 25 and [Formula: see text] BPA doses, which also shifted lineage commitment toward basal progenitors while reducing luminal progenitor cells.
Together, these results confirm and extend previous evidence using a rat model and human prostate epithelial cells that low-dose BPA augments prostate cancer susceptibility and alters adult prostate stem cell homeostasis. Therefore, we propose that BPA exposures may contribute to the increased carcinogenic risk in humans that occurs with aging. https://doi.org/10.1289/EHP3953.
先前的工作表明,低剂量双酚 A(BPA)会在大鼠生命早期增加前列腺癌的风险,且随着年龄的增长而增加。在此,我们报告了旨在解决 BPA 毒性不确定性的 CLARITY-BPA(将学术和监管机构对 BPA 毒性的见解联系起来的联盟)的前列腺特异性研究结果。
我们旨在)重新评估一系列 BPA 暴露是否会导致前列腺病变和/或改变前列腺对激素致癌作用的易感性,以及)测试慢性低剂量 BPA 是否靶向前列腺上皮干细胞和祖细胞。
Sprague-Dawley 大鼠在发育过程中或慢性期每天经口给予载体、乙炔雌二醇(EE)或[公式:见文本]BPA/kg-BW,在一年时评估前列腺病理学。一组发育暴露的大鼠在 90 天时给予睾酮加雌二醇([公式:见文本])植入物,以促进随着年龄增长的致癌作用。通过从连续暴露于[公式:见文本]BPA/kg-BW 六个月的大鼠的背外侧前列腺(DLP)中通过前列腺球体(PS)培养分离上皮干细胞和祖细胞。通过定量实时逆转录聚合酶链反应(qRT-PCR)分析基因表达。
仅暴露于任何剂量的 BPA 均不会引起前列腺病变。然而,用 EE、2.5、250 或[公式:见文本]BPA/kg-BW 加[公式:见文本]处理的大鼠表现出更严重的侧前列腺上皮内瘤形成(PIN),并且在暴露于[公式:见文本]-BW 的肿瘤大鼠中,DLP 导管腺癌的多发性明显升高。通过 PS 数量评估的 DLP 干细胞,在慢性 EE 和[公式:见文本]暴露下增加了一倍。PS 大小反映了祖细胞的增殖,在 25 和[公式:见文本]BPA 剂量下更大,同时将谱系定向朝向基底祖细胞,而减少了管腔祖细胞。
这些结果共同证实并扩展了先前使用大鼠模型和人前列腺上皮细胞的证据,表明低剂量 BPA 会增加前列腺癌的易感性,并改变成年前列腺干细胞的体内平衡。因此,我们提出 BPA 暴露可能导致与年龄相关的人类致癌风险增加。https://doi.org/10.1289/EHP3953.